CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
iCo Therapeutics Inc. Company Snapshot
iCo Therapeutics Inc. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares iCo Therapeutics Inc. with three other miscellaneous service companies in North America: US Stem Cell Inc of the United States (2010 sales of $46,383.00 of which 100% was MyoCell), Diffusion Pharmaceuticals Inc of the United States ($40,189.00 of which 100% was Events), and ImmunoVaccine Inc. (76,105.00 Canadian Dollars [US$60,786.59 ] ).

Sales Analysis.
   
   
 
  Stock Performance Chart for iCo Therapeutics Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): .04
(Figures in Canadian Dollars)
1 Week 0.0%   13 Weeks 0.0%  
4 Weeks 0.0%   52 Weeks 0.0%  
 
iCo Therapeutics Inc. Key Data:
  Ticker: ICO Country: Canada
  Exchanges: VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2010 Sales 100,000
(Year Ending Jan 2011).
Employees: 7
  Currency: Canadian Dollars Market Cap: 3,378,309
  Fiscal Yr Ends: December Shares Outstanding: 84,457,713
  Share Type: Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.